{"gene":"APH1A","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":2010,"finding":"A trimeric PS1/Pen2/Aph1a complex is catalytically active as a gamma-secretase, capable of cleaving Notch and APP substrates in the absence of nicastrin; nicastrin acts to stabilize the complex but is not required for substrate recognition or catalysis. The NCT-independent activity requires PS1, Pen2, and Aph1a but can tolerate knockdown of PS2 or Aph1b.","method":"siRNA knockdown in NCT-deficient mouse embryonic fibroblast lines, gamma-secretase inhibitor blocking, endogenous Notch cleavage assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent NCT-deficient cell lines, inhibitor validation, selective siRNA knockdown panel with multiple orthogonal readouts","pmids":["20130175"],"is_preprint":false},{"year":2005,"finding":"Reconstituted gamma-secretase complex from Sf9 cells co-expressing PS1, nicastrin, aph-1a, and pen-2 is enzymatically active, processing C99 (APP substrate) and the Notch-like substrate N160, and displays characteristic sensitivity to gamma-secretase inhibitors and upregulation of Abeta42 by FAD mutations.","method":"Baculovirus co-infection reconstitution in Sf9 cells, in vitro cleavage assays for C99 and N160, inhibitor sensitivity assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution of the complex in insect cells with functional substrate cleavage assays and FAD mutation characterization in a single rigorous study","pmids":["15766275"],"is_preprint":false},{"year":2005,"finding":"RNAi-mediated silencing of APH-1a decreases full-length PS1 levels in H4 cells expressing either wild-type PS1 or the FAD-linked Delta9 PS1 mutant, establishing that APH-1a supports PS1 stability/metabolism within the gamma-secretase complex.","method":"RNAi knockdown in H4 neuroglioma cells stably expressing wt or FAD mutant PS1, immunoblot for PS1-FL and PS1 fragments","journal":"Journal of molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean RNAi knockdown with defined molecular readout, single lab, single method","pmids":["15781968"],"is_preprint":false},{"year":2006,"finding":"HIF-1 transcriptionally activates the APH-1A promoter by binding to a 271-bp regulatory region; chemical hypoxia (NiCl2) increases APH-1A mRNA and protein, leading to increased gamma-secretase activity as measured by elevated Abeta secretion and increased Notch intracellular domain (NICD) levels, without affecting other gamma-secretase complex components.","method":"5'-flanking region characterization, promoter mutagenesis, gel shift (EMSA), NiCl2 hypoxia treatment, Abeta ELISA, APP CTF and NICD immunoblot","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter mutagenesis, EMSA, and functional Abeta/NICD readouts in a single study, single lab","pmids":["16645044"],"is_preprint":false},{"year":2006,"finding":"Endogenous APH1a protein does not undergo proteasomal degradation under physiological conditions; proteasome inhibitors enhance overexpressed (myc-tagged) but not endogenous APH1a, and purified 20S proteasome fails to cleave APH1a in vitro.","method":"Proteasome inhibitor treatment (ZIE, lactacystin) in HEK-293 cells, TSM1 neurons, and primary cortical neurons; in vitro degradation assay with purified 20S proteasome and cell extracts","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro proteasome cleavage assay combined with cell-based inhibitor experiments across multiple cell types, single lab","pmids":["16302845"],"is_preprint":false},{"year":2007,"finding":"Endogenous Aph-1a resists proteolysis by recombinant caspases and by endogenous or purified proteasome in vitro, confirming that neither caspases nor the proteasome are the physiological degradation machinery for Aph-1a.","method":"In vitro cleavage assays with recombinant caspases and purified/endogenous proteasome; proteasome inhibitor treatment of cells","journal":"Neuro-degenerative diseases","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct in vitro enzymatic assays with purified proteases, corroborating prior study from same lab","pmids":["17596710"],"is_preprint":false},{"year":2011,"finding":"The transcription factor YY1 binds the APH-1A promoter at the -980G allele with increased affinity; YY1 overexpression activates the APH-1A promoter (~2.7-fold) and increases APH-1A mRNA and protein, resulting in higher gamma-secretase activity and Abeta42 generation.","method":"EMSA, dual-luciferase reporter assay, YY1 overexpression and siRNA knockdown in N2A and HEK293 cells, Abeta42 measurement","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus reporter assay plus gain/loss-of-function experiments, single lab, multiple orthogonal methods","pmids":["21443683"],"is_preprint":false},{"year":2019,"finding":"APH-1A contains an internal water and ion-containing cavity within the gamma-secretase complex; molecular dynamics and umbrella sampling simulations indicate APH-1A can store water molecules and allow influx of extracellular cations into its hydrophilic cavity, but cannot transport ions intracellularly, suggesting a potential structural/regulatory role beyond complex stabilization.","method":"Molecular dynamics simulation, umbrella sampling, based on cryo-EM structure of gamma-secretase","journal":"ACS chemical neuroscience","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational simulation only, no experimental validation of the proposed ion/water transport function","pmids":["30979338"],"is_preprint":false},{"year":2022,"finding":"GPCR kinases (GRKs) phosphorylate APH1A at intracellular loop 2 (ICL2) and the C terminus, generating distinct phosphorylation barcodes that differentially regulate recruitment of beta-arrestin 2 (βarr2) to APH1A and gamma-secretase-mediated Abeta generation. Molecular dynamics simulations revealed that the βarr2 finger loop domain interacts with ICL2 and ICL3 of APH1A in a manner analogous to GPCR-β-arrestin complexes.","method":"Phosphorylation assays, Co-immunoprecipitation of APH1A with βarr2, Abeta measurement, molecular dynamics simulation, mutagenesis of phosphorylation sites","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct phosphorylation assays, Co-IP, functional Abeta readout, and structural modeling in single study, single lab","pmids":["35858570"],"is_preprint":false},{"year":2019,"finding":"miR-151-5p targets APH1a mRNA (validated by luciferase reporter assay); blocking miR-151-5p upregulates APH1a protein and impairs hippocampal contextual fear memory formation, placing APH1a downstream of miR-151-5p in a memory-related signaling context.","method":"Luciferase reporter assay for miR-151-5p targeting of APH1a 3'UTR, in vivo miR-151-5p inhibition with behavioral fear conditioning assay","journal":"RNA biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — luciferase reporter validation of direct targeting plus in vivo functional readout, single lab","pmids":["30663934"],"is_preprint":false},{"year":2026,"finding":"miR-151-5p directly targets APH1A mRNA; overexpression of APH1A promotes neural stem cell (NSC) proliferation by elevating Notch intracellular domain (NICD) levels, phenocopying miR-151-5p knockout, placing APH1A as a direct effector of gamma-secretase/Notch signaling in NSC fate determination during neocortical development.","method":"Conditional miR-151-5p knockout in mouse, APH1A overexpression, NICD immunoblot, SOX2 immunostaining, NSC proliferation assays","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse, gain-of-function rescue experiment, molecular NICD readout, multiple orthogonal methods in single study","pmids":["42167224"],"is_preprint":false}],"current_model":"APH1A is an obligate seven-transmembrane subunit of the γ-secretase complex that stabilizes the complex and is required (along with PS1 and Pen2) for intramembrane cleavage of APP and Notch substrates; its expression is transcriptionally controlled by HIF-1 and YY1, its activity is post-translationally regulated by GRK-mediated phosphorylation of ICL2 and the C terminus that recruits β-arrestin 2 to modulate Aβ generation, and it is post-transcriptionally repressed by miR-151-5p to fine-tune Notch signaling during neural stem cell fate decisions."},"narrative":{"mechanistic_narrative":"APH1A is an obligate subunit of the γ-secretase complex that supports the intramembrane proteolysis of substrates including APP and Notch [PMID:15766275, PMID:20130175]. Functional reconstitution of PS1, nicastrin, APH-1a, and Pen-2 in insect cells produces an active protease that cleaves the APP-derived C99 substrate and a Notch-like substrate with the expected inhibitor sensitivity and FAD-mutation-driven Aβ42 elevation [PMID:15766275], and APH-1a together with PS1 and Pen2 is sufficient for catalysis even without nicastrin, which serves a stabilizing rather than catalytic role [PMID:20130175]. Within the complex APH-1a maintains PS1 levels [PMID:15781968], and structurally it harbors an internal water- and cation-containing hydrophilic cavity [PMID:30979338]. APH1A expression and activity are regulated at multiple levels: HIF-1 and YY1 transcriptionally activate the APH-1A promoter to raise APH-1A protein and γ-secretase output (Aβ and NICD) [PMID:16645044, PMID:21443683], GRK-mediated phosphorylation of intracellular loop 2 and the C terminus generates phosphorylation barcodes that recruit β-arrestin 2 to modulate Aβ generation [PMID:35858570], and miR-151-5p directly represses APH1A mRNA [PMID:30663934, PMID:42167224]. Through this miRNA-controlled axis, APH1A acts as a γ-secretase/Notch effector: its overexpression elevates NICD to promote neural stem cell proliferation during neocortical development [PMID:42167224] and influences hippocampal memory formation [PMID:30663934]. Endogenous APH-1a is notably resistant to degradation by the proteasome and caspases [PMID:16302845, PMID:17596710].","teleology":[{"year":2005,"claim":"Established that APH-1a is an essential component of an enzymatically active γ-secretase by reconstituting the four-subunit complex and demonstrating substrate cleavage.","evidence":"Baculovirus co-expression of PS1, nicastrin, aph-1a, pen-2 in Sf9 cells with in vitro C99 and N160 cleavage and inhibitor/FAD-mutation assays","pmids":["15766275"],"confidence":"High","gaps":["Did not resolve the individual contribution of APH-1a versus the other subunits to catalysis","No structural mechanism of substrate engagement"]},{"year":2005,"claim":"Showed APH-1a supports the stability of the catalytic PS1 subunit, defining a structural/maturation role within the complex.","evidence":"RNAi knockdown of APH-1a in H4 cells expressing wt or FAD Δ9 PS1 with PS1 immunoblot","pmids":["15781968"],"confidence":"Medium","gaps":["Single lab, single method","Mechanism by which APH-1a stabilizes PS1 not defined"]},{"year":2006,"claim":"Identified APH1A as a degradation-resistant protein, ruling out proteasomal turnover as a regulatory mechanism for the endogenous subunit.","evidence":"Proteasome inhibitor treatment across multiple cell types and in vitro 20S proteasome cleavage assay","pmids":["16302845"],"confidence":"Medium","gaps":["Physiological degradation machinery for APH1A not identified","Overexpressed protein behaved differently from endogenous"]},{"year":2006,"claim":"Revealed transcriptional control of APH1A by HIF-1, linking hypoxia to increased γ-secretase activity.","evidence":"Promoter mutagenesis, EMSA, NiCl2 hypoxia, Aβ ELISA and NICD/CTF immunoblot","pmids":["16645044"],"confidence":"Medium","gaps":["Single lab","In vivo relevance of hypoxic induction not tested"]},{"year":2007,"claim":"Confirmed that neither caspases nor the proteasome degrade endogenous APH-1a, reinforcing its unusual stability.","evidence":"In vitro cleavage assays with recombinant caspases and purified/endogenous proteasome","pmids":["17596710"],"confidence":"Medium","gaps":["Actual turnover pathway remains unknown","Corroborates same lab's prior work"]},{"year":2010,"claim":"Demonstrated that PS1/Pen2/APH-1a is sufficient for γ-secretase catalysis without nicastrin, refining nicastrin's role to complex stabilization.","evidence":"siRNA knockdown panel in NCT-deficient mouse embryonic fibroblasts with endogenous Notch cleavage and inhibitor validation","pmids":["20130175"],"confidence":"High","gaps":["Did not establish whether NCT-independent activity occurs at physiological substrate levels","APH-1b/PS2 dispensability shown but not the basis of isoform selectivity"]},{"year":2011,"claim":"Identified YY1 as an allele-specific transcriptional activator of APH1A, connecting a promoter polymorphism to γ-secretase output.","evidence":"EMSA, dual-luciferase reporter, YY1 gain/loss-of-function in N2A and HEK293 cells with Aβ42 measurement","pmids":["21443683"],"confidence":"Medium","gaps":["Single lab","In vivo and disease-association significance of the -980G allele not established"]},{"year":2019,"claim":"Proposed a structural cavity in APH-1A capable of storing water and admitting cations, hinting at a role beyond scaffolding.","evidence":"Molecular dynamics and umbrella sampling simulations on the cryo-EM γ-secretase structure","pmids":["30979338"],"confidence":"Low","gaps":["Computational only, no experimental validation of ion/water handling","Functional consequence for catalysis untested"]},{"year":2019,"claim":"Established miR-151-5p as a direct post-transcriptional repressor of APH1a with consequences for memory formation.","evidence":"Luciferase reporter validation of 3'UTR targeting plus in vivo miR-151-5p inhibition with fear conditioning","pmids":["30663934"],"confidence":"Medium","gaps":["Single lab","Whether γ-secretase/Notch activity mediates the memory phenotype not directly tested here"]},{"year":2022,"claim":"Defined GRK phosphorylation of APH1A ICL2 and C terminus as a regulatory barcode that recruits β-arrestin 2 to tune Aβ generation, importing GPCR-like regulation into γ-secretase control.","evidence":"Phosphorylation assays, APH1A–βarr2 Co-IP, Aβ measurement, site mutagenesis and molecular dynamics","pmids":["35858570"],"confidence":"Medium","gaps":["Specific GRK isoforms responsible not fully resolved","Reciprocal validation and in vivo relevance limited"]},{"year":2026,"claim":"Placed APH1A as a direct downstream effector of the miR-151-5p axis in neural stem cell fate, acting through NICD elevation to promote proliferation.","evidence":"Conditional miR-151-5p knockout mouse, APH1A overexpression rescue, NICD immunoblot and SOX2/NSC proliferation assays","pmids":["42167224"],"confidence":"Medium","gaps":["Does not separate APH1A's Notch effect from broader γ-secretase substrate processing","Single study"]},{"year":null,"claim":"The physiological turnover pathway for endogenous APH1A and the in vivo significance of its GRK/β-arrestin and structural cavity regulation remain unresolved.","evidence":"No timeline finding identifies the degradation machinery or validates the cavity function experimentally","pmids":[],"confidence":"Low","gaps":["Endogenous degradation route unknown","Cavity ion/water role unvalidated","GRK isoform specificity and physiological context incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,2]}],"localization":[],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,10]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10]}],"complexes":["γ-secretase complex"],"partners":["PSEN1","NCSTN","PSENEN","ARRB2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96BI3","full_name":"Gamma-secretase subunit APH-1A","aliases":["Aph-1alpha","Presenilin-stabilization factor"],"length_aa":265,"mass_kda":29.0,"function":"Non-catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:12297508, PubMed:12522139, PubMed:12679784, PubMed:12763021, PubMed:25043039, PubMed:26280335, PubMed:30598546, PubMed:30630874). Required for normal gamma-secretase assembly (PubMed:12471034, PubMed:12522139, PubMed:12763021, PubMed:19369254). The gamma-secretase complex plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, and by regulating cytosolic CTNNB1 levels (Probable)","subcellular_location":"Endoplasmic reticulum membrane; Golgi apparatus, Golgi stack membrane","url":"https://www.uniprot.org/uniprotkb/Q96BI3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/APH1A","classification":"Not Classified","n_dependent_lines":57,"n_total_lines":1208,"dependency_fraction":0.04718543046357616},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/APH1A","total_profiled":1310},"omim":[{"mim_id":"607632","title":"PRESENILIN ENHANCER, GAMMA-SECRETASE SUBUNIT; PSENEN","url":"https://www.omim.org/entry/607632"},{"mim_id":"607630","title":"APH1 HOMOLOG B, GAMMA-SECRETASE SUBUNIT; APH1B","url":"https://www.omim.org/entry/607630"},{"mim_id":"607629","title":"APH1 HOMOLOG A, GAMMA SECRETASE SUBUNIT; APH1A","url":"https://www.omim.org/entry/607629"},{"mim_id":"605254","title":"NICASTRIN; NCSTN","url":"https://www.omim.org/entry/605254"},{"mim_id":"600759","title":"PRESENILIN 2; PSEN2","url":"https://www.omim.org/entry/600759"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/APH1A"},"hgnc":{"alias_symbol":["APH-1A","CGI-78"],"prev_symbol":[]},"alphafold":{"accession":"Q96BI3","domains":[{"cath_id":"-","chopping":"1-260","consensus_level":"medium","plddt":91.6395,"start":1,"end":260}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96BI3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96BI3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96BI3-F1-predicted_aligned_error_v6.png","plddt_mean":91.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=APH1A","jax_strain_url":"https://www.jax.org/strain/search?query=APH1A"},"sequence":{"accession":"Q96BI3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96BI3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96BI3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96BI3"}},"corpus_meta":[{"pmid":"16645044","id":"PMC_16645044","title":"Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/16645044","citation_count":93,"is_preprint":false},{"pmid":"20130175","id":"PMC_20130175","title":"Gamma-secretase composed of PS1/Pen2/Aph1a can cleave notch and amyloid precursor protein in the absence of nicastrin.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20130175","citation_count":78,"is_preprint":false},{"pmid":"15781968","id":"PMC_15781968","title":"Effects of RNAi-mediated silencing of PEN-2, APH-1a, and nicastrin on wild-type vs FAD mutant forms of presenilin 1.","date":"2005","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/15781968","citation_count":23,"is_preprint":false},{"pmid":"15766275","id":"PMC_15766275","title":"Characterization of the reconstituted gamma-secretase complex from Sf9 cells co-expressing presenilin 1, nicastrin [correction of nacastrin], aph-1a, and pen-2.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15766275","citation_count":21,"is_preprint":false},{"pmid":"16302845","id":"PMC_16302845","title":"Catabolism of endogenous and overexpressed APH1a and PEN2: evidence for artifactual involvement of the proteasome in the degradation of overexpressed proteins.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16302845","citation_count":16,"is_preprint":false},{"pmid":"30979338","id":"PMC_30979338","title":"APH-1A Component of γ-Secretase Forms an Internal Water and Ion-Containing Cavity.","date":"2019","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30979338","citation_count":9,"is_preprint":false},{"pmid":"30663934","id":"PMC_30663934","title":"miR-151-5p modulates APH1a expression to participate in contextual fear memory formation.","date":"2019","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/30663934","citation_count":8,"is_preprint":false},{"pmid":"35858570","id":"PMC_35858570","title":"GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35858570","citation_count":8,"is_preprint":false},{"pmid":"21443683","id":"PMC_21443683","title":"The -980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease.","date":"2011","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/21443683","citation_count":8,"is_preprint":false},{"pmid":"17596710","id":"PMC_17596710","title":"Study on the putative contribution of caspases and the proteasome to the degradation of Aph-1a and Pen-2.","date":"2007","source":"Neuro-degenerative diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17596710","citation_count":3,"is_preprint":false},{"pmid":"26738354","id":"PMC_26738354","title":"The effects and interactions of APOE and APH-1A polymorphisms in Alzheimer disease.","date":"2015","source":"Turkish journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26738354","citation_count":1,"is_preprint":false},{"pmid":"42167224","id":"PMC_42167224","title":"miR-151-5p regulates neural stem cell fate by targeting APH1A to modulate Notch signaling gradients.","date":"2026","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/42167224","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7994,"output_tokens":2834,"usd":0.033246,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10087,"output_tokens":3323,"usd":0.066755,"stage2_stop_reason":"end_turn"},"total_usd":0.100001,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"A trimeric PS1/Pen2/Aph1a complex is catalytically active as a gamma-secretase, capable of cleaving Notch and APP substrates in the absence of nicastrin; nicastrin acts to stabilize the complex but is not required for substrate recognition or catalysis. The NCT-independent activity requires PS1, Pen2, and Aph1a but can tolerate knockdown of PS2 or Aph1b.\",\n      \"method\": \"siRNA knockdown in NCT-deficient mouse embryonic fibroblast lines, gamma-secretase inhibitor blocking, endogenous Notch cleavage assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent NCT-deficient cell lines, inhibitor validation, selective siRNA knockdown panel with multiple orthogonal readouts\",\n      \"pmids\": [\"20130175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Reconstituted gamma-secretase complex from Sf9 cells co-expressing PS1, nicastrin, aph-1a, and pen-2 is enzymatically active, processing C99 (APP substrate) and the Notch-like substrate N160, and displays characteristic sensitivity to gamma-secretase inhibitors and upregulation of Abeta42 by FAD mutations.\",\n      \"method\": \"Baculovirus co-infection reconstitution in Sf9 cells, in vitro cleavage assays for C99 and N160, inhibitor sensitivity assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution of the complex in insect cells with functional substrate cleavage assays and FAD mutation characterization in a single rigorous study\",\n      \"pmids\": [\"15766275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RNAi-mediated silencing of APH-1a decreases full-length PS1 levels in H4 cells expressing either wild-type PS1 or the FAD-linked Delta9 PS1 mutant, establishing that APH-1a supports PS1 stability/metabolism within the gamma-secretase complex.\",\n      \"method\": \"RNAi knockdown in H4 neuroglioma cells stably expressing wt or FAD mutant PS1, immunoblot for PS1-FL and PS1 fragments\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean RNAi knockdown with defined molecular readout, single lab, single method\",\n      \"pmids\": [\"15781968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HIF-1 transcriptionally activates the APH-1A promoter by binding to a 271-bp regulatory region; chemical hypoxia (NiCl2) increases APH-1A mRNA and protein, leading to increased gamma-secretase activity as measured by elevated Abeta secretion and increased Notch intracellular domain (NICD) levels, without affecting other gamma-secretase complex components.\",\n      \"method\": \"5'-flanking region characterization, promoter mutagenesis, gel shift (EMSA), NiCl2 hypoxia treatment, Abeta ELISA, APP CTF and NICD immunoblot\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter mutagenesis, EMSA, and functional Abeta/NICD readouts in a single study, single lab\",\n      \"pmids\": [\"16645044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Endogenous APH1a protein does not undergo proteasomal degradation under physiological conditions; proteasome inhibitors enhance overexpressed (myc-tagged) but not endogenous APH1a, and purified 20S proteasome fails to cleave APH1a in vitro.\",\n      \"method\": \"Proteasome inhibitor treatment (ZIE, lactacystin) in HEK-293 cells, TSM1 neurons, and primary cortical neurons; in vitro degradation assay with purified 20S proteasome and cell extracts\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro proteasome cleavage assay combined with cell-based inhibitor experiments across multiple cell types, single lab\",\n      \"pmids\": [\"16302845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Endogenous Aph-1a resists proteolysis by recombinant caspases and by endogenous or purified proteasome in vitro, confirming that neither caspases nor the proteasome are the physiological degradation machinery for Aph-1a.\",\n      \"method\": \"In vitro cleavage assays with recombinant caspases and purified/endogenous proteasome; proteasome inhibitor treatment of cells\",\n      \"journal\": \"Neuro-degenerative diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro enzymatic assays with purified proteases, corroborating prior study from same lab\",\n      \"pmids\": [\"17596710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The transcription factor YY1 binds the APH-1A promoter at the -980G allele with increased affinity; YY1 overexpression activates the APH-1A promoter (~2.7-fold) and increases APH-1A mRNA and protein, resulting in higher gamma-secretase activity and Abeta42 generation.\",\n      \"method\": \"EMSA, dual-luciferase reporter assay, YY1 overexpression and siRNA knockdown in N2A and HEK293 cells, Abeta42 measurement\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus reporter assay plus gain/loss-of-function experiments, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"21443683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"APH-1A contains an internal water and ion-containing cavity within the gamma-secretase complex; molecular dynamics and umbrella sampling simulations indicate APH-1A can store water molecules and allow influx of extracellular cations into its hydrophilic cavity, but cannot transport ions intracellularly, suggesting a potential structural/regulatory role beyond complex stabilization.\",\n      \"method\": \"Molecular dynamics simulation, umbrella sampling, based on cryo-EM structure of gamma-secretase\",\n      \"journal\": \"ACS chemical neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational simulation only, no experimental validation of the proposed ion/water transport function\",\n      \"pmids\": [\"30979338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GPCR kinases (GRKs) phosphorylate APH1A at intracellular loop 2 (ICL2) and the C terminus, generating distinct phosphorylation barcodes that differentially regulate recruitment of beta-arrestin 2 (βarr2) to APH1A and gamma-secretase-mediated Abeta generation. Molecular dynamics simulations revealed that the βarr2 finger loop domain interacts with ICL2 and ICL3 of APH1A in a manner analogous to GPCR-β-arrestin complexes.\",\n      \"method\": \"Phosphorylation assays, Co-immunoprecipitation of APH1A with βarr2, Abeta measurement, molecular dynamics simulation, mutagenesis of phosphorylation sites\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct phosphorylation assays, Co-IP, functional Abeta readout, and structural modeling in single study, single lab\",\n      \"pmids\": [\"35858570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-151-5p targets APH1a mRNA (validated by luciferase reporter assay); blocking miR-151-5p upregulates APH1a protein and impairs hippocampal contextual fear memory formation, placing APH1a downstream of miR-151-5p in a memory-related signaling context.\",\n      \"method\": \"Luciferase reporter assay for miR-151-5p targeting of APH1a 3'UTR, in vivo miR-151-5p inhibition with behavioral fear conditioning assay\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — luciferase reporter validation of direct targeting plus in vivo functional readout, single lab\",\n      \"pmids\": [\"30663934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"miR-151-5p directly targets APH1A mRNA; overexpression of APH1A promotes neural stem cell (NSC) proliferation by elevating Notch intracellular domain (NICD) levels, phenocopying miR-151-5p knockout, placing APH1A as a direct effector of gamma-secretase/Notch signaling in NSC fate determination during neocortical development.\",\n      \"method\": \"Conditional miR-151-5p knockout in mouse, APH1A overexpression, NICD immunoblot, SOX2 immunostaining, NSC proliferation assays\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse, gain-of-function rescue experiment, molecular NICD readout, multiple orthogonal methods in single study\",\n      \"pmids\": [\"42167224\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"APH1A is an obligate seven-transmembrane subunit of the γ-secretase complex that stabilizes the complex and is required (along with PS1 and Pen2) for intramembrane cleavage of APP and Notch substrates; its expression is transcriptionally controlled by HIF-1 and YY1, its activity is post-translationally regulated by GRK-mediated phosphorylation of ICL2 and the C terminus that recruits β-arrestin 2 to modulate Aβ generation, and it is post-transcriptionally repressed by miR-151-5p to fine-tune Notch signaling during neural stem cell fate decisions.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"APH1A is an obligate subunit of the γ-secretase complex that supports the intramembrane proteolysis of substrates including APP and Notch [#1, #0]. Functional reconstitution of PS1, nicastrin, APH-1a, and Pen-2 in insect cells produces an active protease that cleaves the APP-derived C99 substrate and a Notch-like substrate with the expected inhibitor sensitivity and FAD-mutation-driven Aβ42 elevation [#1], and APH-1a together with PS1 and Pen2 is sufficient for catalysis even without nicastrin, which serves a stabilizing rather than catalytic role [#0]. Within the complex APH-1a maintains PS1 levels [#2], and structurally it harbors an internal water- and cation-containing hydrophilic cavity [#7]. APH1A expression and activity are regulated at multiple levels: HIF-1 and YY1 transcriptionally activate the APH-1A promoter to raise APH-1A protein and γ-secretase output (Aβ and NICD) [#3, #6], GRK-mediated phosphorylation of intracellular loop 2 and the C terminus generates phosphorylation barcodes that recruit β-arrestin 2 to modulate Aβ generation [#8], and miR-151-5p directly represses APH1A mRNA [#9, #10]. Through this miRNA-controlled axis, APH1A acts as a γ-secretase/Notch effector: its overexpression elevates NICD to promote neural stem cell proliferation during neocortical development [#10] and influences hippocampal memory formation [#9]. Endogenous APH-1a is notably resistant to degradation by the proteasome and caspases [#4, #5].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established that APH-1a is an essential component of an enzymatically active γ-secretase by reconstituting the four-subunit complex and demonstrating substrate cleavage.\",\n      \"evidence\": \"Baculovirus co-expression of PS1, nicastrin, aph-1a, pen-2 in Sf9 cells with in vitro C99 and N160 cleavage and inhibitor/FAD-mutation assays\",\n      \"pmids\": [\"15766275\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the individual contribution of APH-1a versus the other subunits to catalysis\", \"No structural mechanism of substrate engagement\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed APH-1a supports the stability of the catalytic PS1 subunit, defining a structural/maturation role within the complex.\",\n      \"evidence\": \"RNAi knockdown of APH-1a in H4 cells expressing wt or FAD Δ9 PS1 with PS1 immunoblot\",\n      \"pmids\": [\"15781968\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, single method\", \"Mechanism by which APH-1a stabilizes PS1 not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified APH1A as a degradation-resistant protein, ruling out proteasomal turnover as a regulatory mechanism for the endogenous subunit.\",\n      \"evidence\": \"Proteasome inhibitor treatment across multiple cell types and in vitro 20S proteasome cleavage assay\",\n      \"pmids\": [\"16302845\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological degradation machinery for APH1A not identified\", \"Overexpressed protein behaved differently from endogenous\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Revealed transcriptional control of APH1A by HIF-1, linking hypoxia to increased γ-secretase activity.\",\n      \"evidence\": \"Promoter mutagenesis, EMSA, NiCl2 hypoxia, Aβ ELISA and NICD/CTF immunoblot\",\n      \"pmids\": [\"16645044\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo relevance of hypoxic induction not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Confirmed that neither caspases nor the proteasome degrade endogenous APH-1a, reinforcing its unusual stability.\",\n      \"evidence\": \"In vitro cleavage assays with recombinant caspases and purified/endogenous proteasome\",\n      \"pmids\": [\"17596710\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Actual turnover pathway remains unknown\", \"Corroborates same lab's prior work\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated that PS1/Pen2/APH-1a is sufficient for γ-secretase catalysis without nicastrin, refining nicastrin's role to complex stabilization.\",\n      \"evidence\": \"siRNA knockdown panel in NCT-deficient mouse embryonic fibroblasts with endogenous Notch cleavage and inhibitor validation\",\n      \"pmids\": [\"20130175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether NCT-independent activity occurs at physiological substrate levels\", \"APH-1b/PS2 dispensability shown but not the basis of isoform selectivity\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified YY1 as an allele-specific transcriptional activator of APH1A, connecting a promoter polymorphism to γ-secretase output.\",\n      \"evidence\": \"EMSA, dual-luciferase reporter, YY1 gain/loss-of-function in N2A and HEK293 cells with Aβ42 measurement\",\n      \"pmids\": [\"21443683\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo and disease-association significance of the -980G allele not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Proposed a structural cavity in APH-1A capable of storing water and admitting cations, hinting at a role beyond scaffolding.\",\n      \"evidence\": \"Molecular dynamics and umbrella sampling simulations on the cryo-EM γ-secretase structure\",\n      \"pmids\": [\"30979338\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational only, no experimental validation of ion/water handling\", \"Functional consequence for catalysis untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established miR-151-5p as a direct post-transcriptional repressor of APH1a with consequences for memory formation.\",\n      \"evidence\": \"Luciferase reporter validation of 3'UTR targeting plus in vivo miR-151-5p inhibition with fear conditioning\",\n      \"pmids\": [\"30663934\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Whether γ-secretase/Notch activity mediates the memory phenotype not directly tested here\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined GRK phosphorylation of APH1A ICL2 and C terminus as a regulatory barcode that recruits β-arrestin 2 to tune Aβ generation, importing GPCR-like regulation into γ-secretase control.\",\n      \"evidence\": \"Phosphorylation assays, APH1A–βarr2 Co-IP, Aβ measurement, site mutagenesis and molecular dynamics\",\n      \"pmids\": [\"35858570\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific GRK isoforms responsible not fully resolved\", \"Reciprocal validation and in vivo relevance limited\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Placed APH1A as a direct downstream effector of the miR-151-5p axis in neural stem cell fate, acting through NICD elevation to promote proliferation.\",\n      \"evidence\": \"Conditional miR-151-5p knockout mouse, APH1A overexpression rescue, NICD immunoblot and SOX2/NSC proliferation assays\",\n      \"pmids\": [\"42167224\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not separate APH1A's Notch effect from broader γ-secretase substrate processing\", \"Single study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The physiological turnover pathway for endogenous APH1A and the in vivo significance of its GRK/β-arrestin and structural cavity regulation remain unresolved.\",\n      \"evidence\": \"No timeline finding identifies the degradation machinery or validates the cavity function experimentally\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Endogenous degradation route unknown\", \"Cavity ion/water role unvalidated\", \"GRK isoform specificity and physiological context incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 10]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"complexes\": [\"γ-secretase complex\"],\n    \"partners\": [\"PSEN1\", \"NCSTN\", \"PSENEN\", \"ARRB2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}